Overview

Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)

Status:
Completed
Trial end date:
1998-09-01
Target enrollment:
Participant gender:
Summary
This is a study of plasma HBP -levels of a previously published trial of G-CSF in critically ill patients (Pettila et al. Critical Care Medicine 2000). The original study was a prospective, randomised, double-blind, placebo-controlled trial of filgrastim in patients with acute respiratory failure requiring intubation. In this substudy, the investigators evaluated the effect of filgrastim on HBP -concentrations in critically ill patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborator:
The Swedish Research Council
Treatments:
Antimicrobial Cationic Peptides
Calcium heparin
Heparin
Lenograstim